Skip to content
WeighLab
Menu
Ranked #80 · Grade C

Queen RX review

Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

Visit Queen RX Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$100/mo (quarterly plan, compounded)
Tirzepatide
Not disclosed
Coverage
45 states
Brand-name
Compounded only

Semaglutide · modeled / year

$1,200

The Index scorecard

Queen RX scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month71/100
Price Transparency86/100
Nationwide Access78/100
Formulation Options58/100
Clinical Oversight70/100
Contract Flexibility61/100

Where the value is

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

The tradeoffs

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

The bottom line

Best for: Cost-first shoppers who want budget-conscious patients seeking low-cost compounded GLP-1. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

Ranked #80 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Queen RX.

The 24 programs nearest this one

Pricing, states and verification reflect Queen RX's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Queen RX's site. Not medical advice; see our disclosure.

← Back to the value leaderboard